Basen and hypoglycaemia Patient Reports February 12, 2012

Basen Side Effects Report #4680990-2
Basen side effect was reported by a Physician from on June 30, 2004. Female patient, 62 years of age, was diagnosed with diabetes mellitus, prophylaxis and was treated with Basen. After drug was administered, patient experienced the following side effects: diabetes mellitus inadequate control, hypoglycaemia, meningitis viral, tremor. Basen dosage: 0.6 MG, UNK. During the same period patient was treated with PHENYTOIN, GASTER, STARSIS #AJ, STARSIS #AJ, STARSIS #AJ, STARSIS #AJ. Patient was hospitalized. Patient recovered.

Basen Side Effects Report #4577160-5
Basen side effect was reported by a Physician from on June 30, 2004. Female patient, 62 years of age, was diagnosed with blood glucose increased, prophylaxis, diabetes mellitus and was treated with Basen. After drug was administered, patient experienced the following side effects: diabetes mellitus inadequate control, hypoglycaemia, meningitis viral, tremor. Basen dosage: 0.2 MG, TID. During the same period patient was treated with PHENYTOIN, GASTER, STARSIS #AJ, STARSIS #AJ, STARSIS #AJ. Patient was hospitalized. Patient recovered.

Basen Side Effects Report #5044138-7
Basen side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2006. Female patient, 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Basen. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. Basen dosage: .9 MG, QD. During the same period patient was treated with INNOLET, NOVORAPID, NOVOLIN R, ADALAT, BLOPRESS, ASPIRIN, MAGNESIUM. Patient was hospitalized. Patient recovered.

Basen Side Effects Report #5051151-2
Basen side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2006. Female patient, 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Basen. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. Basen dosage: .9 MG, QD. During the same period patient was treated with INNOLET, NOVORAPID, NOVOLIN R, ADALAT, BLOPRESS, ASPIRIN, MAGNESIUM. Patient was hospitalized. Patient recovered.